The global pharmaceutical market is undergoing a major transformation driven by innovation, rising healthcare demand, and ...

Clark County judge finds defendant's public statements were not made in good faith. The ruling caps months of legal proceedings brought by the inventor of a wellness technology used in over 700 ...

MMJ International Holdings Moves to Join Federal Lawsuit Challenging CMS Hemp-CBD Medicare Pilot as Preliminary Injunction Hearing Approaches. WASHINGTON, D.C. / ACCESS Newswire / April 11, 2026 / MMJ ...

A decade of pharma-native impact across the industry, and a vision for what comes nextCHAPEL HILL, N.C., & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--#10years--AESARA, a leading Value & Access agency ...

BFA Law is investigating whether Simply Good Foods committed securities fraud relating to its expansion of OWYN products leading to a stock drop of 18%.NEW YORK--(BUSINESS WIRE)--$SMPL #BFA--Leading ...

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of ordinary shares of uniQure N.V. (NASDAQ: QURE) between September 24, 2025, ...

CHICAGO, IL / ACCESS Newswire / April 10, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today confirmed that ...

TURKU, FI / ACCESS Newswire / April 10, 2026 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Shareholders of Faron Pharmaceuticals Ltd (the "Company") are notified of the Annual General Meeting (the ...

PharmNovo AB announces that the drug product for its lead candidate PN6047 has been manufactured for the upcoming Phase IIa proof-of-concept (PoC) study in neuropathic pain.PharmNovo is a ...

BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws.NEW YORK--(BUSINESS WIRE)--$ADMA ...

Against the backdrop of ongoing transformation in the global pharmaceutical industry, policy factors are increasingly becoming a core variable shaping the development of innovative drugs. From reforms ...

Between 10% and 20% of people living with Parkinson's present symptoms before the age of 501OFF episodes remain underdiagnosed, delaying treatment optimisation and increasing disease burden2,3Bial’s ...